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A novel model of hyaline cartilage-producing chondrocytes for the 
healing of articular lesions: a possible glimpse into the future
G. Maor1, R. Goldberg2, G. Nierenberg3;
1Faculty Of Medicine-anatomy And Cell Biology, Technion-Israel 
Institute of Technology, Haifa, Israel, 2Anatomy And Cell Biology, 
Technion-Israel Institute of Technology, Haifa, Israel, 3Orthopaedics,
Rambam Medical Center, Haifa, Israel
Purpose: Damage to surfacing cartilage of joints, caused by trauma 
or osteoarthritis, results in pain, and altered quality of life. Since 
cartilage tissue does not heal spontaneously, permenat joint 
functional rehabilitation may be achieved by replavement the 
lesion with cartilage producing cells. The current study is aimed at 
developing highly reproducible, genuine hyaline carilage-producing 
cells. 
Methods and Materials: A novel chondrocytes cell culture originating 
from neonatal porcine-derived mandibular condyle (MC) is proposed. 
MC-derived chondrocytes (MCDC) spontaneously differentiate into 
mature chondrocytes. These cells express type II collagen and 
aggrecan; thus producing a genuine hyaline cartilage. Prolonged 
.$%$DVMUVSFTGPSNBDPOUJOVPVTDBSUJMBHF¾MN	$BSUJNPWF
UIBU
can be mechanically handled and re-plated while preserving its 
proliferation and differentiation activities. 
Results: Our preclinical studies, conducted in goats, have shown 
that both MCDC cells and Cartimove implanted in knee articular 
lesions developed into aggrecan and type II collagen containing 
surfacing tissue. Six months post implantation an almost full 
thickness layer is observed. The newly produced cartilage forms a 
close integration with adjacent cartilage and subchondral bone. No 
signs of immunoreactivity, or of cells/tissue necrosis are observed 
indicating of no rejection reaction. 
Conclusions: Hence, we propose that porcine-derived MCDC cells, or 
BTDBSUJMBHF¾MN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an authentic hyaline cartilage without provoking immunological 
reaction. 
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Combined autologous bone and chondrocyte transplantation 
(CARES-technology) or osteochondritis dissecans
J. Bruns1, J. Steinhagen2;
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Eichen“, Hamburg, HAMBURG, Germany, 2Lehrstuhl F. Orthopaedie, 
University Hospital Hamburg, Hamburg, Germany
Purpose: Femoral osteochondritis dissecans (OCD) is common. For 
the repair different procedures are recommended. We report on 
the treatment of OCD-lesions at the medial femoral condyle with a 
combination autologous bone-plug transplantation for the repair of 
the subchondral damage combined with autologous chondrocyte 
transplantation (CARES®-technique: autologous chondrocytes 
dispensed in a rat-collagen matrix). 
Methods and Materials: 22 patients with OCD-lesions (grade III 
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chondrocytes harvested. In the second operation the subchondral 
sclerosis was removed and the bony defect restored with autologous 
cancellous bone plugs harvested from the proximal tibia. The 
cartilage layer was reconstructed with matrix-associated autologous 
chondrocytes. Partial weight-bearing was limited to 15 kg for the 
¾STUXFFLTBOEVOUJMUIFth week to 30 kg, afterwards full weight-
bearing was allowed. Sports activities were restricted for one year. 
Follow-up was performed using the IKDC-score and the patients and 
physicians contentment scale (excellent-poor). The IKDC-score was 
analysed statistically comparing the preoperative score with the 
one-year follow-up results. 
Results: Follow-up was possible in all 22 patients. The mean 
preoperative IKDC-score was 35.1 pts., after 1 yr. 67.7 pts. the mean 
change to baseline was 29.3 (p< 0.0001). Results were clearly 
depending on the size of the defect and the duration of symptoms. 
The content-ment of the patients/physician resulted in 9/8 excellent, 
9/9 good, 4/3 fair and 0/2 poor results. 
Conclusions: These results are promising. Further follow-up is 
necessary to show stability of these results. In addition, comparative 
studies are desireable. 
P74
Second generation ACI with BioCart ™II: Experience of the 
Souraski Medical Centre
R. Arbel
Hod Hasharon, Israel
Purpose: Clinical evaluation of a novel autologous chondrocyte 
implant, BioCart™II for cartilage repair. 
Methods and Materials: #JP$BSU** JT B NBUSJYBTTJTUFE ¾CSJO
hyaluronic acid-based implant containing autologous chondrocytes 
propagated with a unique growth factor variant to maintain their 
chondrogenic potential. The scaffold is a porous open channel 
structure enabling a three dimensional distribution of the cells and 
full thickness repair. Nine patients aged 17-50, with cartilage lesions 
diagnosed by MRI underwent arthroscopy and biopsy from the 
antero-lateral margin of the intercondylar notch. Two to three weeks 
later, BioCart™II was implanted through a small 4-5cm longitudinal 
parapatellar incision. Deep lesions were treated with two layers. 
Rehabilitation included 4-6 weeks of non-weight bearing and CPM, 
followed by 3 weeks of partial weight. Full activities were resumed at 
4-6 months and follow-up was 3-22 months. 
Results: At diagnosis all patients scored under 4 points in the 
subjective ICRS questionnaire improving to over 6 post operation. 
The IKDC score for all patients improved from grades C and D before 
the operation to A or B post operation. Second look arthroscopy 
and biopsy on one patient due to pain and sensation of catching, 
showed excellent coverage, full integration and new hyaline-type 
cartilage. Six months post operative MRI on 6 patients showed good 
integration of the graft with signs of bone edema at the implantation 
site. 
Conclusions: BioCart™II is safe, effective and user-friendly 
both for the patient and the surgeon. The short time from biopsy 
to implantation and good to excellent clinical outcome further 
encourage the continued use of this technique and product. 
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A prospective study of alginate seeded with mature allogenic 
human chondrocytes in the treatment of articular cartilage 
defects
K.F. Almqvist1, A. D‘Hollander1, P.C. Verdonk2, R. Verdonk3,
K.L. Verstraete4, G. Verbruggen5;
1Dept. Of Orthopaedic Surgery And Fysiotherapy, Ghent University 
Hospital, Gent, Belgium, 2Department Of Orthopaedic Surgery, Ghent 
University Hospital, Ghent, Belgium, 3Department Of Orthopaedic 
Surgery, Gent University Hospital, Gent, Belgium, 4Radiology, Ghent 
University, Gent, Belgium, 5Department Of Rheumatology, Ghent 
university Hospital, Ghent, Belgium
Purpose: Aim of the Study: To produce tissue-engineered cartilage 
by human articular chondrocytes cultured in a biocompatible, 
biodegradable matrix for the treatment of (osteo)chondral lesions. 
Methods and Materials: Earlier studies have shown that 
chondrocytes proliferate in alginate, and synthesize a cartilage-
like matrix for up to 8 weeks. Allogenic human chondrocytes were 
cultured in 1.0% alginate beads for 2 weeks before implantation into 
cartilage defects of the knee joint. Prior to the surgical intervention a 
small part of the alginate beads was dissolved and the chondrocytes 
were tested for their phenotypical stability. The (osteo)chondral 
lesion of the femoral condyle in 22 patients (3 lateral – 19 medial) 
was debrided by an open technique, and covered by an autologous 
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Parameters that were followed pre- and postoperatively, were the 
Lequesne index, the WOMAC, the KOOS and VAS-score, and Gd-DTPA 
MRI. A follow-up arthroscopy to assess the macroscopic aspect and 
the integration of repair tissue into surrounding native cartilage was 
performed at 12 months postoperatively. 
Results: Clinically, major adverse reactions to the scaffold seeded 
with the cartilage cells, were not observed. The results (mean follow-
up: 19months) of clinical examination of the involved joint as well as 
the functional scores improved with time. Follow-up arthroscopy at 
12 months showed an intact articular surface, with good integration 
into the surrounding cartilage, and a practically normal indentation 
was felt on palpation. 
Conclusions:  This surgical procedure is performed in one step. 
Biodegradable, biocompatible scaffolds could be used in the 
USFBUNFOUPGDBSUJMBHFEFGFDUTXJUIUIFBEWBOUBHFUIBUUIFBSUJ¾DJBM
matrix provides an initial support to the chondrocytes, making the 
implant theoretically initially biomechanically superior to the model 
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